Market Overview

3 After-Hours Movers: Earnings & Clinical Data Pushing Stocks Up

Share:

U.S. stocks closed lower on Monday trading, as investors anticipated the first presidential debate between candidates Hillary Clinton and Donald Trump.

After the market closed, SYNNEX Corporation (NYSE: SNX) reported Q3 results. EPS of $1.73 and revenue of $3.67 billion (up 10.2 percent year over year) beat the Street’s consensus by $0.17 and $180 million, respectively. Management expects Q4 revenue of $3.83 billion to $3.93 billion, above estimates for $3.77 billion, and EPS of $2.06 to $2.11, also ahead of expectations for $1.93. The company raised its quarterly dividend by 25 percent, to $0.25 per share. Shares of SYNNEX traded up 5.25 percent on Monday afternoon.

Thor Industries, Inc. (NYSE: THO) gained about 1.2 percent after the bell rang, driven by a top and bottom line beat. Q4 EPS of $1.57 came in $0.24 ahead of expectations, while revenue of $1.29 billion beat estimates by $20 million.

Kite Pharma Inc (NASDAQ: KITE) rose 6.5 percent in Monday’s after-hours session after the company announced impressive results for its Phase 1/2 clinical trial for KTE-C19 in diffuse large B-cell lymphoma (DLBCL).

The product candidate displayed a 76 percent objective response rate in patients with diffuse large B-cell lymphoma (DLBCL) who had failed to respond to chemo. In addition, the drug showed 47 percent complete remissions (CR) among this group.

Posted-In: Biotech Earnings News Guidance Dividends After-Hours Center Movers General

 

Related Articles (SNX + KITE)

View Comments and Join the Discussion!

Todd Gordon's SPDR Gold Trust ETF Trade

Debates Could Swing A Big Chunk Of Voters